Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison (Q28218927)

From Wikidata

Jump to navigation Jump to search

scientific article (publication date: 10 February 2007)

Language	Label	Description	Also known as
English	Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison	scientific article (publication date: 10 February 2007)

Statements

scholarly article

0 references

0 references

Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison (English)

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

Christopher P Cannon

5

object named as

Christopher P Cannon

0 references

author name string

Loren Laine

1

0 references

Sean P Curtis

2

0 references

Byron Cryer

3

0 references

Amarjot Kaur

4

0 references

language of work or name

0 references

publication date

10 February 2007

0 references

0 references

369

0 references

9560

0 references

465-73

0 references

Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960234-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960234-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960234-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960234-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960234-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960234-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960234-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Unmet needs in non-steroidal anti-inflammatory drug-induced upper gastrointestinal diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960234-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960234-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960234-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvements with esomeprazole in patients with upper gastrointestinal symptoms taking non-steroidal antiinflammatory drugs, including selective COX-2 inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960234-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Gastrointestinal tolerability of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib compared with nonselective COX-1 and COX-2 inhibitors in osteoarthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960234-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis: upper gastrointestinal tolerability of valdecoxib, a cyclooxygenase-2-specific inhibitor, compared with nonspecific nonsteroidal anti-inflammatory drugs among patients with osteoarthritis and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960234-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Dyspepsia tolerability from the patients' perspective: a comparison of celecoxib with diclofenac

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960234-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960234-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960234-7

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960234-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960234-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960234-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960234-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960234-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960234-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960234-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960234-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960234-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of gastroduodenal ulcers associated with valdecoxib compared with that of ibuprofen and diclofenac in patients with osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960234-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Valdecoxib is as effective as diclofenac in the management of rheumatoid arthritis with a lower incidence of gastroduodenal ulcers: results of a 26-week trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960234-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960234-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Gastrointestinal health care resource utilization with chronic use of COX-2-specific inhibitors versus traditional NSAIDs.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960234-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(07)60234-7

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28218927&oldid=1398067160"